Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.

Journal of clinical microbiology - 1 Nov 2010

Chong Hin Siong, Dagg Rebecca, Malik Richard, Chen Sharon, Carter Dee

Abstract excerpt

Cryptococcosis is primarily caused by Cryptococcus neoformans and Cryptococcus gattii. These two pathogenic species each divide into four distinct molecular genotypes. In this study, we examined whether genotype influenced susceptibility to antifungal drugs used to treat cryptococcosis using the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Australia
Share to Azoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Canada

Share to Cryptococcosis

Share to Cryptococcus gattii

Share to Cryptococcus neoformans

Share to Fluconazole

Source

Open in PubMed Open full text

Identifiers

PMID: 20844209
DOI: 10.1128/JCM.01271-10
PMCID: PMC3020851

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20844209-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.PMID 20844209Read ↗

Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex.Semantic proximity Read ↗

Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.Semantic proximity Read ↗

Antifungal susceptibility of clinical Cryptococcus gattii isolates from Colombia varies among molecular types.Semantic proximity Read ↗

Antifungal drug susceptibility and phylogenetic diversity among Cryptococcus isolates from dogs and cats in North America.Semantic proximity Read ↗

Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.Semantic proximity Read ↗

Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complexSemantic proximity Read ↗

Genetic diversity and antifungal susceptibilities of environmental Cryptococcus neoformans and Cryptococcus gattii species complexesSemantic proximity Read ↗

Molecular type distribution and fluconazole susceptibility of clinical Cryptococcus gattii isolates from South African laboratory-based surveillance, 2005-2013.Semantic proximity Read ↗

Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study GroupSemantic proximity Read ↗

Antifungal susceptibility and molecular characteristics of Cryptococcus spp. based on whole-genome sequencing in Zhejiang Province, ChinaSemantic proximity Read ↗

Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.Semantic proximity Read ↗

Molecular Epidemiology and Microbiological Characteristics of <i>Cryptococcus gattii</i> VGII isolates from ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.